Study people after a severe allergic reaction
Part of Immune system & allergy clinical trials.
This trial follows people who have had anaphylaxis (a severe, life-threatening allergic reaction) within the last year. The goal is to better understand what happens over time so doctors can improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had anaphylaxis within the past 12 months
- The reaction is considered a severe allergic reaction needing urgent treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what causes severe allergic reactions during surgery. It helps doctors find out which medicine or substance triggered the reaction, so they can avoid it in the future.
This trial tests if inhaled epinephrine can safely treat moderate to severe allergic reactions (grade 2 or higher) that can happen during allergy skin tests, oral food or drug challenges, or allergy shots. It is for people who have had such reactions in the past or are at risk and are planning to undergo one of these procedures.
This trial tests whether using a steroid drug can help treat allergic reactions to food. If you have a food allergy that causes immediate symptoms (like hives or trouble breathing), this study may help find better ways to manage those reactions.
This study tests a new epinephrine auto-injector (FMXIN002) compared to the standard EpiPen in people with a history of hay fever or seasonal allergies. The goal is to see if the new device works just as well and is safe in a controlled clinic setting.
This study is a follow-up survey for people who have had a severe allergic reaction (anaphylaxis) to certain foods and are already in a larger allergy registry. By answering questions online, you can help researchers understand more about living with food allergies.
This trial is for people with moderate to severe allergic diseases who are about to start a biologic medicine (a targeted allergy treatment). It also looks at people who have more than one allergy condition, aiming to improve coordinated care across allergy problems.
Hear when a new Anaphylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.